Cyclic fertilin-derived peptide stimulates in vitro human embryo development

Area of Science:

• Reproductive biology
• Developmental biology
• Biochemistry

Background:

• Fertilin β, a sperm-binding protein, plays a role in fertilization.
• Cyclic fertilin peptide mimics the disintegrin domain of Fertilin β.
• This peptide has shown potential in enhancing sperm-oocyte interactions and early embryo development.

Purpose of the Study:

• To investigate the effects of cyclic fertilin peptide on preimplantation human embryogenesis.
• To determine the optimal concentration of cyclic fertilin peptide for embryo development.
• To elucidate the mechanism of action of cyclic fertilin peptide on human embryos.

Main Methods:

• Dose-response study using thawed human embryos (3-4 cells stage).
• Evaluation of inner cell mass (ICM), trophectoderm (TE), and total cell numbers in blastocysts.
• Immunofluorescence and gene expression analysis (Clariom D microarrays) to study the mechanism.

Main Results:

• Cyclic fertilin peptide improved blastocyst formation by approximately 20% at 1 μM concentration.
• Significantly increased TE cell number (doubled) without affecting ICM.
• Increased in vitro hatching rate from 14% to 45%.

Conclusions:

• Cyclic fertilin peptide stimulates TE growth and influences ICM through transcriptional activation.
• The peptide dramatically improves human embryo development potential in vitro.
• Early supplementation of culture medium with cyclic fertilin peptide could enhance assisted reproductive technology outcomes.